- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02327520
Clostridium Difficile Infection: the First Report in Southeast Asia by 2010 Nationwide Study
December 24, 2014 updated by: Rapat Pittayanon, MD, King Chulalongkorn Memorial Hospital
The Burden of Clostridium Difficile Infection in Thai Population: the First Report in Southeast Asia by 2010 Nationwide Study
The authors retrieved in-patient medical data, including the expense, from the 2010 Thailand Nationwide Hospital Admission Database, which is part of the National Health Security Office (NHSO).
The diagnosis of digestive diseases with any form of colitis listed in the causes, either as principal diagnosis or co-morbidity, coding by the ICD-10 was recorded.
The inclusion criteria were: 1) diagnosis of enterocolitis due to Clostridium difficile (ICD10-A07); and 2) age of more than 18 years.
If the data was incomplete, the case was excluded.
The baseline characteristics, including age, sex, co-morbidity disease and history of endoscopy or surgery, were recorded.
The burden of CDI was evaluated by length of hospital stay (LOS), mortality rate, and hospital charge.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
204666
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The patients with the diagnosis of Clostridium difficile (ICD10-A07) with age of more than 18 years were included.
Description
Inclusion Criteria:
- The patients with the diagnosis of Clostridium difficile (ICD10-A07)
- Age of more than 18 years.
Exclusion Criteria:
- Data incompleted
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Colitis with CDI
Patients who diagnosed with CDI will be analysed
|
All patients will be treated with standard treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Death rate and length of hospital stay in CDI during admission
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
|
Length of hospital stay(LOS), mortality rate and hospital charge were used as the indicators for evaluating the burden of CDI.
|
participants will be followed for the duration of hospital stay, an expected average of 2 weeks
|
Hospital charge of CDI
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
|
Length of hospital stay(LOS), mortality rate and hospital charge were used as the indicators for evaluating the burden of CDI.
|
participants will be followed for the duration of hospital stay, an expected average of 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Rapat Pittayanon, MD, King Chulalongkorn Memorial Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
December 1, 2010
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
December 22, 2014
First Submitted That Met QC Criteria
December 24, 2014
First Posted (Estimate)
December 30, 2014
Study Record Updates
Last Update Posted (Estimate)
December 30, 2014
Last Update Submitted That Met QC Criteria
December 24, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RP009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clostridium Difficile Infection
-
Vedanta Biosciences, Inc.CompletedClostridium Difficile Infection | Clostridium Difficile Infection Recurrence | Clostridium Difficile | CDI | Clostridioides Difficile Infection | Clostridioides Difficile | Clostridioides Difficile Infection RecurrenceUnited States, Canada
-
Vedanta Biosciences, Inc.Not yet recruitingClostridium Difficile Infection Recurrence | Recurrent Clostridium Difficile Infection | Clostridium Difficile | Diarrhea Infectious | CDI | Clostridium Difficile Infections | Clostridioides Difficile Infection | C.Difficile Diarrhea | Clostridioides Difficile Infection Recurrence | C. Diff Infection
-
University of PennsylvaniaTerminatedSevere Clostridium Difficile Infection | Severe-Complicated/Fulminant Clostridium Difficile InfectionUnited States
-
Mikrobiomik Healthcare Company S.L.CompletedRecurrent Clostridium Difficile Infection | Primary Clostridium Difficile InfectionSpain
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences Institute; North Carolina...CompletedClostridium DifficileUnited States
-
University Health Network, TorontoTerminatedRecurrent Clostridium Difficile Infection | Laboratory Confirmed Clostridium Difficile InfectionCanada
-
University of Wisconsin, MadisonAgency for Healthcare Research and Quality (AHRQ)Enrolling by invitationClostridium Difficile Infection | Clostridium Difficile | C Difficile ColitisUnited States
-
DeinoveRecruitingClostridium Difficile (C. Difficile)United States, Canada
-
Hospital Universitario Evangelico de CuritibaNot yet recruitingClostridium Difficile Infections
-
MJM BontenUniversiteit Antwerpen; Universitätsklinikum Köln; Da VolterraCompletedClostridium DifficileGermany, Spain, France, Greece, Netherlands, Romania
Clinical Trials on Colitis with CDI treatment
-
Xiuli ZuoQilu Hospital of Shandong UniversityUnknown
-
University of CologneUnknownClostridium Difficile Infection | Clostridium Difficile DiarrheaGermany
-
University of Illinois at ChicagoMerck Sharp & Dohme LLCCompletedClostridium Difficile Infection | Clostridium Difficile Infection RecurrenceUnited States
-
Affiliated Hospital to Academy of Military Medical...CompletedUlcerative Colitis | Dopamine Dysregulation SyndromeChina
-
Ferring PharmaceuticalsTerminated
-
Rambam Health Care CampusFondazione Policlinico Universitario Agostino Gemelli IRCCS; Imperial College... and other collaboratorsRecruitingClostridioides Difficile InfectionIsrael, Canada, Hungary, Italy, Lithuania, United Kingdom
-
Chuncheon Sacred Heart HospitalHallym University Medical CenterCompletedHelicobacter Pylori InfectionKorea, Republic of
-
Astellas Pharma S.A.S.Completed
-
Universidad Complutense de MadridRecruitingMalocclusion, Angle Class II | DistalizationSpain
-
Helsinki University Central HospitalActive, not recruitingto Omit Radioiodine Treatment Safely in Patients With Low -Risk Papillary Thyroid Cancer With Seize of 11-20mm